Type 2 Diabetes Mellitus Recruiting Phase 4 Trials for Metformin (DB00331)

Also known as: T2DM / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Type Two / Type Two Diabetes Mellitus / NIDDM / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus Non-insulin-dependent / Type 2 Diabetes / Diabetes, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes (T2D) / Diabetes Mellitus,Type 2 / Diabetes Mellitus. Type 2 / Diabetes Mellitus Type 2 / Diabetes Mellitus Type-2 / Type-2 Diabetes Mellitus / Diabetes Mellitus 2 Type / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus, Type 2 (T2DM) / T2DM (Type 2 Diabetes Mellitus) / Type 2 Diabetes Mellitus (T2D) / Diabetes Mellitus, Type 2 / Type-2 Diabetes / Diabetes Type 2 / Type 2 Diabetes (T2DM) / Type II Diabetes / Diabetes, Type II / Type-II Diabetes Mellitus / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / Diabetes Type II / Type II; Diabetes / Diabetes Mellitus Type II / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03982381SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 DiabetesTreatment
NCT02315287Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes ManagementTreatment
NCT01717911ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate HyperglycemiaTreatment
NCT02438397the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix InsulinTreatment
NCT02501616Effect of Dapagliflozine on Systemic and Renal Endothelial FunctionTreatment
NCT03794336Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveTreatment
NCT03196362Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 DiabetesTreatment
NCT02911792Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With HyperfiltrationTreatment
NCT03819790The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South AsiansTreatment
NCT03499704A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin TherapyTreatment
NCT02501850The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)Treatment
NCT02409238Insulin Resistance and Mild Cognitive Impairment (IRMCI) StudyTreatment